Source: PRECEYES Blog

PRECEYES Blog First-In-Human Robot-Assisted Subretinal Drug Delivery Under Local Anaesthesia

Eindhoven, the Netherlands, November 14, 2021 – This study reports the results of a first-in-human study using a robotic device to assist subretinal drug delivery in patients undergoing vitreoretinal surgery for macular haemorrhage. After standard vitrectomy, intraoperative OCT-guided subretinal injection of tissue plasminogen activator (TPA) was performed either by robot-assisted […]

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Gerrit Naus's photo - Co-Founder & CEO of Preceyes

Co-Founder & CEO

Gerrit Naus

CEO Approval Rating

90/100

Read more